ocular paraneoplastic syndrome
MeSH: D059545ORPHA: 71505
Overview
ocular manifestation secondary to various neoplasms in which antibodies to antigens of the primary tumor cross-react with ocular antigens
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with ocular paraneoplastic syndrome, sourced from HPO and Orphanet clinical annotations.
Visual lossPhotophobiaMalignant genitourinary tract tumorReduced visual acuityAdult-onset night blindnessERG: Reduced dark-adapted b-wave amplitudeProgressive visual field defectsAutoimmune antibody positivitySmall cell lung carcinomaPhotopsiaFemale reproductive system neoplasmNeoplasm of the breastAnti-recoverin antibody positivityOptic disc pallorCentral scotomaRetinal atrophyConstriction of peripheral visual fieldHematological neoplasmDyschromatopsiaRetinal pigment epithelial atrophyGranular macular appearanceUterine neoplasmTesticular neoplasmHodgkin lymphomaParacentral scotomaFoveal hyporeflective spaces on macular OCTDiffuse cerebellar atrophyThymomaOptic atrophyVisual hallucinationNeoplasm of the pancreasColon cancerPancreatic adenocarcinomaVitritisCutaneous melanomaProstate cancer
Classification & Codes
MeSH Code
D059545Orphanet Code
ORPHA:71505ocular paraneoplastic syndrome
| MeSH | D059545 |
| Orphanet | ORPHA:71505 |
| Treatments | 0 drug(s) |
| Symptoms on record | 36 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO